# Maxcyte, Inc.: Form 8-K, filed Sep 22, 2025

- Company: [Maxcyte, Inc.](/companies/mxct.md) (CIK 1287098)
- Form: 8-K
- Filed: 2025-09-22
- Accepted by EDGAR: Sep 22, 2025, 16:39 ET
- Period: 2025-09-22
- Accession: 0001104659-25-092162
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1287098/000110465925092162/mxct-20250922x8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1287098/000110465925092162/

## Items reported

- Item 2.05: Exit or disposal costs
- Item 7.01: Regulation FD disclosure
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1287098/000110465925092162/mxct-20250922x8k.htm

Filed Sep 22, 2025.
Source: SEC EDGAR, the filing index for accession 0001104659-25-092162. Last ingested by Listed: Nov 2, 2026, 10:20 ET. No prices; not investment advice.